Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Analysis of the prognostic significance of solute carrier (SLC) family 39 genes in breast cancer.

Bioscience reports - 28 Aug 2020

Liu Limei, Yang Jiaomin, Wang Chao

Abstract excerpt

BACKGROUND: Breast cancer (BC) is the most common malignancy in females and remains a main cause of cancer-associated death worldwide. The solute carrier (SLC) groups of membrane transport proteins, which control the influx of zinc, participate in ranging of physiological processes and may provide novel therapeutic targets of cancers. However, the prognostic values of individual SLC family 39 (SLC39A) genes in...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Biomarkers, Tumor
Share to Breast Neoplasms
Share to Cation Transport Proteins

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Computational Biology

Share to Databases, Genetic

Share to Gene Expression Regulation, Neoplastic

Share to MCF-7 Cells

Source

Open in PubMed Open full text

Identifiers

PMID: 32744318
DOI: 10.1042/BSR20200764
PMCID: PMC7426635

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Analysis of the prognostic significance of solute carrier (SLC) family 39 genes in breast cancer.PMID 32744318Read ↗

Pan-Cancer Analysis of the Solute Carrier Family 39 Genes in Relation to Oncogenic, Immune Infiltrating, and Therapeutic TargetsSemantic proximity Read ↗

A Novel Prognostic Biomarker of Luminal Breast Cancer: High CD39 Expression Is Related to Poor SurvivalSemantic proximity Read ↗

Evaluation of the prognostic values of solute carrier (SLC) family 39 genes for patients with lung adenocarcinomaSemantic proximity Read ↗

Unveiling the prognostic and therapeutic landscape of the zinc transporter protein SLC39A family in colorectal cancer through multi-omics and machine learning approaches.Semantic proximity Read ↗

SLC39A1 Contribute to Malignant Progression and Have Clinical Prognostic Impact in GliomasSemantic proximity Read ↗

SLC39A1 contribute to malignant progression and have clinical prognostic impact in gliomasSemantic proximity Read ↗

Prognostic Value of HIF1A-AS3 in Breast cancerSemantic proximity Read ↗

ATP binding cassette subfamily B member 9 (ABCB9) is a prognostic indicator of overall survival in ovarian cancerSemantic proximity Read ↗

The Tissue Expression of MCT3, MCT8, and MCT9 Genes in Women with Breast CancerSemantic proximity Read ↗

Impact of MIR31HG polymorphisms on risk of breast cancer in Chinese women.Semantic proximity Read ↗

Exome sequencing study of Russian breast cancer patients suggests a predisposing role for USP39.Semantic proximity Read ↗

The multifunctional solute carrier 3A2 (SLC3A2) confers a poor prognosis in the highly proliferative breast cancer subtypesSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.